Screener
Insight Molecular Diagnostics Inc. IMDX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$20K+20.0% | -$23K+20.7% | -$26K+13.3% | -$29K+6.5% | -$25K-213% | ||
| $239K-53.9% | $32K-98.5% | $1.14M-23.4% | $260K+126% | $518K+398% | ||
| $82K-54.4% | $17K-97.9% | $643K-26.0% | $121K+181% | $180K+463% | ||
| $157K-53.6% | $15K-98.9% | $496K-19.6% | $139K+93.1% | $338K+369% | ||
| 65.7%+0.4pp | 46.9%-15.1pp | 43.5%+2.0pp | 53.5%-9.1pp | 65.3%-4.0pp | ||
| $4.49M+37.2% | $4.95M+69.4% | $5.83M+158% | $3.88M+37.7% | $3.27M+33.3% | ||
| $1.92M+31.2% | $2.4M+99.2% | $2.29M+90.6% | $1.39M+32.9% | $1.46M+71.2% | ||
| $2.87M+8.5% | $2.99M-4.0% | $2.33M-9.1% | $2.55M-0.8% | $2.65M+10.0% | ||
| $11.56M+13.5% | $4.43M-45.5% | $23.93M-30.1% | $11.19M-17.5% | $10.18M+117% | ||
| -$11.4M-15.9% | -$4.41M+35.1% | -$23.44M+30.3% | -$11.05M+18.3% | -$9.84M-112% | ||
| -4,770.7%-2,871pp | -13,790.6%-13,473pp | -2,057.5%+205pp | -4,249.2%+7,503pp | -1,900%+2,554pp | ||
| $142K+42.0% | $123K-3.9% | $480K+314% | $194K+782% | $100K-2.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$11.26M-15.6% | -$4.29M+35.7% | -$22.96M+31.5% | -$10.85M+19.6% | -$9.74M-115% | ||
| -4,711.3%-2,831pp | -13,406.3%-13,094pp | -2,015.4%+240pp | -4,174.6%+7,558pp | -1,880.7%+2,475pp | ||
| -$0.31-3.3% | -$0.12+53.8% | -$0.74+67.8% | -$0.34+65.3% | -$0.30+16.7% | ||
| -$10.74M-15.7% | -$3.78M+40.1% | -$22.87M+30.9% | -$10.46M+20.7% | -$9.28M-114% | ||
| -4,492.5%-2,700pp | -11,818.8%-11,523pp | -2,008.1%+218pp | -4,024.6%+7,451pp | -1,792.1%+2,369pp | ||
| -$11.4M-15.9% | -$4.41M+35.1% | -$23.44M+30.3% | -$11.05M+18.3% | -$9.84M-112% |
FAQ
- What is Insight Molecular Diagnostics Inc.'s revenue?
- Insight Molecular Diagnostics Inc. (IMDX) generated $1.7M in revenue over the trailing twelve months, down 60.8% year over year.
- Is Insight Molecular Diagnostics Inc. profitable?
- Insight Molecular Diagnostics Inc. is not currently profitable: it reported a net loss of $49.4M over the trailing twelve months, a -2955.6% net margin.
- What are Insight Molecular Diagnostics Inc.'s profit margins?
- Gross margin is 48.3% and operating margin is -3011.9%, with a -2955.6% net margin.
- What is Insight Molecular Diagnostics Inc.'s earnings per share?
- Insight Molecular Diagnostics Inc.'s diluted EPS over the trailing twelve months is $-1.51.
- Where does Insight Molecular Diagnostics Inc.'s income statement data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
